Direkt zum Inhalt
Merck

RNases Disrupt the Adaptive Potential of Malignant Cells: Perspectives for Therapy.

Frontiers in pharmacology (2019-09-03)
Vladimir Alexandrovich Mitkevich, Irina Yu Petrushanko, Alexander Alexander Makarov
ZUSAMMENFASSUNG

Exogenous RNases are selectively toxic to tumor cells. The reasons for this selectivity are not quite clear and should be searched for in the properties that distinguish malignant from normal cells. During onco-transformation, cells acquire properties allowing them to adapt to the altered microenvironment, such as resistance to hypoxia, changes in intracellular pH, disruption of ion transport, reduced adhesion and increased mobility, and production of specific exosomes. These adaptation mechanisms distinguish malignant cells from normal ones and give them a competitive advantage, ensuring survival and spread in the organism. Here, we analyze if the directed cytotoxic effect of exogenous RNases is linked to the disruption of the adaptive potential of tumor cells and how it can be used in anticancer therapy.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-Glutathione Antibody, clone D8, clone D8, Chemicon®, from mouse